BACKGROUND: Social protection interventions might improve tuberculosis outcomes and could help to control the epidemic in Brazil. The aim of this study was to evaluate the independent effect of the Bolsa Familia Programme (BFP) on tuberculosis treatment outcomes in Brazil. METHODS: We prospectively recruited and followed up individuals (aged ≥18 years) who initiated tuberculosis treatment at 42 health-care centres across seven cities in Brazil, between March 1, 2014, and April 30, 2017. Patients were interviewed at health-care centres and information about individual characteristics, socioeconomic status, living conditions, lifestyle, and comorbidities was recorded. Patients were separated into two groups according to BFP beneficiary status: BFP (exposed) or non-BFP (not exposed). Treatment outcome (cure, dropout, death, or development of drug-resistant tuberculosis or treatment failure) was recorded after 6 months of therapy. Pearson's χ2 test and ANOVA were used to compare tuberculosis treatment outcomes between the two groups, and we estimated the propensity score of being a beneficiary of the BFP using a logit model. We used multinomial regression models to evaluate the effect of the BFP on tuberculosis treatment outcomes. FINDINGS: 1239 individuals were included in the study, of whom 196 (16%) were beneficiaries of the BFP and 1043 (84%) were not. After 6 months of treatment, 912 (87%) of 1043 patients in the non-BFP group and 173 (88%) of 196 patients in the BFP group were cured of tuberculosis, 103 (10%) patients in the non-BFP group and 17 (9%) patients in the BFP group had dropped out, and 25 (3%) patients in the non-BFP group and six (3%) patients in the BFP group had died. Three (<1%) of 1043 patients in the non-BFP group developed drug-resistant tuberculosis. Being a BFP beneficiary had a positive effect for cure (average effect 0·076 [95% CI 0·037 to 0·11]) and a negative effect for dropout (-0·070 [-0·105 to 0·036]) and death (-0·002 [-0·021 to 0·017]). INTERPRETATION: BFP alone had a direct effect on tuberculosis treatment outcome and could greatly contribute to the goals of the WHO End TB Strategy. FUNDING: Brazilian National Council for Scientific and Technological Development (CNPq) and Brazilian Ministry of Health Department of Science and Technology (DECIT).
BACKGROUND: Social protection interventions might improve tuberculosis outcomes and could help to control the epidemic in Brazil. The aim of this study was to evaluate the independent effect of the Bolsa Familia Programme (BFP) on tuberculosis treatment outcomes in Brazil. METHODS: We prospectively recruited and followed up individuals (aged ≥18 years) who initiated tuberculosis treatment at 42 health-care centres across seven cities in Brazil, between March 1, 2014, and April 30, 2017. Patients were interviewed at health-care centres and information about individual characteristics, socioeconomic status, living conditions, lifestyle, and comorbidities was recorded. Patients were separated into two groups according to BFP beneficiary status: BFP (exposed) or non-BFP (not exposed). Treatment outcome (cure, dropout, death, or development of drug-resistant tuberculosis or treatment failure) was recorded after 6 months of therapy. Pearson's χ2 test and ANOVA were used to compare tuberculosis treatment outcomes between the two groups, and we estimated the propensity score of being a beneficiary of the BFP using a logit model. We used multinomial regression models to evaluate the effect of the BFP on tuberculosis treatment outcomes. FINDINGS: 1239 individuals were included in the study, of whom 196 (16%) were beneficiaries of the BFP and 1043 (84%) were not. After 6 months of treatment, 912 (87%) of 1043 patients in the non-BFP group and 173 (88%) of 196 patients in the BFP group were cured of tuberculosis, 103 (10%) patients in the non-BFP group and 17 (9%) patients in the BFP group had dropped out, and 25 (3%) patients in the non-BFP group and six (3%) patients in the BFP group had died. Three (<1%) of 1043 patients in the non-BFP group developed drug-resistant tuberculosis. Being a BFP beneficiary had a positive effect for cure (average effect 0·076 [95% CI 0·037 to 0·11]) and a negative effect for dropout (-0·070 [-0·105 to 0·036]) and death (-0·002 [-0·021 to 0·017]). INTERPRETATION: BFP alone had a direct effect on tuberculosis treatment outcome and could greatly contribute to the goals of the WHO End TB Strategy. FUNDING: Brazilian National Council for Scientific and Technological Development (CNPq) and Brazilian Ministry of Health Department of Science and Technology (DECIT).
Authors: Thaís Zamboni Berra; Ivaneliza Simionato de Assis; Luiz Henrique Arroyo; Marcos Augusto Moraes Arcoverde; Josilene Dália Alves; Laura Terenciani Campoy; Luana Seles Alves; Juliane de Almeida Crispim; Alexandre Tadashi Inomata Bruce; Yan Mathias Alves; Felipe Lima Dos Santos; Severina Alice da Costa Uchôa; Regina Celia Fiorati; Luis Lapão; Ricardo Alexandre Arcêncio Journal: BMJ Open Date: 2020-08-20 Impact factor: 2.692
Authors: Barbara Reis-Santos; Priya Shete; Adelmo Bertolde; Carolina M Sales; Mauro N Sanchez; Denise Arakaki-Sanchez; Kleydson B Andrade; M Gabriela M Gomes; Delia Boccia; Christian Lienhardt; Ethel L Maciel Journal: PLoS One Date: 2019-02-22 Impact factor: 3.240
Authors: George Jó Bezerra Sousa; Thiago Santos Garces; Maria Lúcia Duarte Pereira; Thereza Maria Magalhães Moreira; Germana Maria da Silveira Journal: Rev Lat Am Enfermagem Date: 2019-12-05
Authors: Layana Costa Alves; Mauro Niskier Sanchez; Thomas Hone; Luiz Felipe Pinto; Joilda Silva Nery; Pedro Luiz Tauil; Maurício Lima Barreto; Gerson Oliveira Penna Journal: BMC Public Health Date: 2021-06-29 Impact factor: 3.295
Authors: Julia M Pescarini; Elizabeth Williamson; Joilda S Nery; Anna Ramond; Maria Yury Ichihara; Rosemeire L Fiaccone; Maria Lucia F Penna; Liam Smeeth; Laura C Rodrigues; Gerson O Penna; Elizabeth B Brickley; Mauricio L Barreto Journal: Lancet Infect Dis Date: 2020-02-14 Impact factor: 71.421